BusinessAugust 21, 2026
avexitide
uh-VEK-sih-tide
Definition
A therapeutic peptide candidate being developed for the treatment of metabolic disorders, specifically post-bariatric hypoglycemia.
Etymology
This is a coined pharmaceutical name; it follows standard medical nomenclature patterns for drug development, often combining structural or functional identifiers with conventional medicinal suffix conventions.
In the news
In the article, avexitide is highlighted as a key clinical asset in Amylyx Pharmaceuticals' development pipeline, and its projected 2027 launch is a critical factor for investors evaluating the company's potential earnings growth.
MercadoLibre Stock Leads 3 High Growth Picks Backed By Strong Financial Health
Read the full article ↗Simply Wall Street